New and Emerging Therapies for GPP
Dr. Bachelez discusses the development of IL-36R inhibitors to treat pustular psoriasis and the necessity for further research.
Sunday, August 28, 2022
Resource Tag: ADC
Review of Currently Available Therapies for GPP
Dr. van de Kerkhof reviews the current treatments for generalized pustular psoriasis, there limitations, and the need for improved options.
Sunday, August 28, 2022
How to Diagnose and Assess Severity of GPP
Dr. Burden discusses how to diagnose and measure the severity of pustular psoriasis.
Sunday, August 28, 2022
Clinical Characteristics and Course of GPP
Dr. Choon discusses the characteristics and course of generalized pustular psoriasis.
Sunday, August 28, 2022
Dissecting the Pathophysiology of GPP
Dr. Gudjonsson examines the immunopathogenesis of pustular psoriasis.
Sunday, August 28, 2022
Genetic Determinants of GPP
Dr. Capon examines the genetic mutation of IL36 and its influence on pustular psoriasis.
Sunday, August 28, 2022
What Do We Know about the Epidemiology of GPP?
Dr. Zheng discusses the challenges in the epidemiology of GPP and the varying disease prevalence by country.
Sunday, August 28, 2022
